Nootropics for Depression: NSI-189 Review
NSI-189 would win the award for the most anticipated compound to be trialed in recent years, if there were one. Phase 2 trials for this nootropic ended in December of 2017 and it has all the attention because of its purpose – it will supposedly treat depression. Effectively. We say supposedly be